Diagnostic and monitoring ophthalmic devices market seen reaching $6.54 billion by 2030

The global market for diagnostic and monitoring ophthalmic devices and equipment is projected to grow from $5.14 billion in 2025 to $6.54 billion by 2030, with demand tied to eye disease screening, diabetes-related complications and AI-enabled diagnostics. North America led the market in 2025, while Asia-Pacific ranked second.

Why it matters: - The market supports earlier detection and ongoing management of eye diseases, including glaucoma and retinal disorders. - Growth in diabetes is increasing demand for ophthalmic tools that can help monitor complications such as diabetic retinopathy. - The market’s expansion signals broader adoption of tele-ophthalmology, smart diagnostic platforms and AI-based analytics in eye care.

What happened: - The Business Research Company said the diagnostic and monitoring ophthalmic devices and equipment market will rise from $5.14 billion in 2025 to $5.39 billion in 2026. - The company forecast the market will reach $6.54 billion by 2030, implying a 5.0% CAGR from 2025 to 2030. - The report said North America held the largest share of the global market in 2025. - The report said Asia-Pacific was the second-largest regional market in 2025. - The company made the report available with a free sample and a full version online: the free sample and the full report.

The details: - Diagnostic and monitoring ophthalmic devices are used to diagnose and monitor conditions affecting the retina and cornea. - The devices measure refractive errors and assess lenses, including intraocular lenses. - The equipment also analyzes the visual field to detect abnormalities and track changes over time. - The report linked growth to rising eye disorder incidence, an aging population, more ophthalmic diagnostic centers, higher preventive eye care awareness and imaging technology advances. - The forecast also pointed to stronger demand for early detection of glaucoma and retinal disease, wider tele-ophthalmology use, smart diagnostic platform development, more precision eye care investment and greater use of AI analytics. - One development highlighted in the market is smart contact lenses being developed for continuous glucose monitoring and diabetic retinopathy management. - The International Diabetes Federation said 589 million adults ages 20 to 79 were living with diabetes in 2024, and that number is expected to reach 853 million by 2050. - More than 80% of people with diabetes live in low- and middle-income countries.

Between the lines: - Diabetes is becoming a larger driver for eye-care diagnostics because the disease raises the risk of vision-threatening complications. - The regional ranking suggests mature demand in North America and stronger room for expansion in Asia-Pacific as healthcare spending and patient volumes rise. - The report’s focus on AI, tele-ophthalmology and smart devices suggests the market is shifting from standalone equipment toward connected and data-driven care.

What's next: - The company expects market growth to continue through 2030 as eye-disease screening and diabetes management needs rise. - The 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated trend analysis. - The company provided contact details for its expert and sales teams for follow-up on the report.